TARSUS PHARMACEUTICALS, INC. (TARS) Net margin 2021–2025
TARSUS PHARMACEUTICALS, INC. (TARS) net profit margin by fiscal year — reported net income divided by reported revenue.
-14.6%FY2025 · since FY2021: -24.2% → -14.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -14.6% | +48.8 pp |
| FY2024 | -63.4% | +716.1 pp |
| FY2023 | -779.5% | -539.0 pp |
| FY2022 | -240.5% | -216.3 pp |
| FY2021 | -24.2% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice